347 related articles for article (PubMed ID: 16971403)
1. Saliva is one likely source of leukotriene B4 in exhaled breath condensate.
Gaber F; Acevedo F; Delin I; Sundblad BM; Palmberg L; Larsson K; Kumlin M; Dahlén SE
Eur Respir J; 2006 Dec; 28(6):1229-35. PubMed ID: 16971403
[TBL] [Abstract][Full Text] [Related]
2. Levels of cysteinyl-leukotrienes in exhaled breath condensate are not due to saliva contamination.
Tufvesson E; van Weele LJ; Ekedahl H; Bjermer L
Clin Respir J; 2010 Apr; 4(2):83-8. PubMed ID: 20565481
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children.
Montuschi P; Martello S; Felli M; Mondino C; Barnes PJ; Chiarotti M
Respir Res; 2005 Oct; 6(1):119. PubMed ID: 16236169
[TBL] [Abstract][Full Text] [Related]
4. Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate.
Zihlif N; Paraskakis E; Tripoli C; Lex C; Bush A
Pediatr Pulmonol; 2006 Jun; 41(6):509-14. PubMed ID: 16617444
[TBL] [Abstract][Full Text] [Related]
5. Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4 in exhaled breath condensate.
Montuschi P; Martello S; Felli M; Mondino C; Chiarotti M
Rapid Commun Mass Spectrom; 2004; 18(22):2723-9. PubMed ID: 15499663
[TBL] [Abstract][Full Text] [Related]
6. Exhaled leukotriene B4 in children with community acquired pneumonia.
Carraro S; Andreola B; Alinovi R; Corradi M; Freo L; Da Dalt L; Baraldi E
Pediatr Pulmonol; 2008 Oct; 43(10):982-6. PubMed ID: 18781641
[TBL] [Abstract][Full Text] [Related]
7. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.
Carpagnano GE; Barnes PJ; Geddes DM; Hodson ME; Kharitonov SA
Am J Respir Crit Care Med; 2003 Apr; 167(8):1109-12. PubMed ID: 12684249
[TBL] [Abstract][Full Text] [Related]
8. Implications of prostaglandin D2 and leukotrienes in exhaled breath condensates of asthma.
Uchida Y; Soma T; Nakagome K; Kobayashi T; Nagata M
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):81-88.e1. PubMed ID: 30986547
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath condensate eicosanoid levels associate with asthma and its severity.
Kazani S; Planaguma A; Ono E; Bonini M; Zahid M; Marigowda G; Wechsler ME; Levy BD; Israel E
J Allergy Clin Immunol; 2013 Sep; 132(3):547-553. PubMed ID: 23608729
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 and 8-isoprostane in exhaled breath condensate of children with episodic and persistent asthma.
Caballero Balanzá S; Martorell Aragonés A; Cerdá Mir JC; Belda Ramírez J; Navarro Iváñez R; Navarro Soriano A; Félix Toledo R; Escribano Montaner A
J Investig Allergol Clin Immunol; 2010; 20(3):237-43. PubMed ID: 20635789
[TBL] [Abstract][Full Text] [Related]
11. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.
Carraro S; Corradi M; Zanconato S; Alinovi R; Pasquale MF; Zacchello F; Baraldi E
J Allergy Clin Immunol; 2005 Apr; 115(4):764-70. PubMed ID: 15805996
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory mediators in exhaled breath, induced sputum and saliva.
Simpson JL; Wood LG; Gibson PG
Clin Exp Allergy; 2005 Sep; 35(9):1180-5. PubMed ID: 16164445
[TBL] [Abstract][Full Text] [Related]
13. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
Lehtonen H; Oksa P; Lehtimäki L; Sepponen A; Nieminen R; Kankaanranta H; Saarelainen S; Järvenpää R; Uitti J; Moilanen E
Thorax; 2007 Jul; 62(7):602-7. PubMed ID: 17251310
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene B4, 8-iso-prostaglandin F2 alpha, and pH in exhaled breath condensate from asymptomatic smokers.
Hoffmeyer F; Harth V; Bunger J; Bruning T; Raulf-Heimsoth M
J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():57-60. PubMed ID: 20134040
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath condensate analysis: evaluation of a methodological setting for epidemiological field studies.
Hoffmeyer F; Harth V; Merget R; Goldscheid N; Hainze E; Degens P; Pesch B; Bünger J; Brüning T; Raulf-Heimsoth M
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):289-98. PubMed ID: 18204138
[TBL] [Abstract][Full Text] [Related]
16. Using high-performance liquid chromatography with UV detector to quantify exhaled leukotriene B4 level in nonatopic adults.
Wan GH; Yan DC; Tseng HY; Lee JT; Lin YW
J Formos Med Assoc; 2014 Aug; 113(8):566-8. PubMed ID: 24491995
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
Montuschi P; Macagno F; Parente P; Valente S; Lauriola L; Ciappi G; Kharitonov SA; Barnes PJ; Ciabattoni G
Thorax; 2005 Oct; 60(10):827-33. PubMed ID: 16192367
[TBL] [Abstract][Full Text] [Related]
18. [Determination and clinical implication of leukotriene B(4) and tumor necrosis factor-alpha in condensate of exhaled breath of chronic obstructive pulmonary disease patients].
Chen JL; Chen JR; Tao YJ; Cai YY; Tao GH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):357-60. PubMed ID: 18549718
[TBL] [Abstract][Full Text] [Related]
19. Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate.
Leung TF; Li CY; Yung E; Liu EK; Lam CW; Wong GW
Pediatr Pulmonol; 2006 Jan; 41(1):87-94. PubMed ID: 16292777
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 contributes to exhaled breath condensate and sputum neutrophil chemotaxis in COPD.
Corhay JL; Henket M; Nguyen D; Duysinx B; Sele J; Louis R
Chest; 2009 Oct; 136(4):1047-1054. PubMed ID: 19429719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
